Rationale, aims, and objectives Continuous subcutaneous insulin infusion (CSII; insulin pump) use is increasing. However, there is little information about how this technology is used compared with other insulin delivery methods (ie, injections) by young people with type 1 diabetes mellitus in Australia. This study explored young people's attitudes, perceptions, and experiences with diabetes management comparing those using with those not using CSII, and proportions likely to transition to adult services requiring initiation and/or support for CSII use.
; however, living with CSII is not without challenges. Device malfunction and infusion set/site failures are not uncommon and may increase hypoglycemia or ketoacidosis risk. CSII use has been reported to increase emergency department (ED) presentation rates. [13] [14] [15] Australian data indicate a consistent increase in rates of CSII commencement. 16 By 2011, around 10% of this T1DM population were using this technology, 16 broadly similar to data from Sweden, the Netherlands, and Germany, 17 although lower than those reported in the United States. 18, 19 16 This represents a large number considering that more than half of all new cases of T1DM occur in people younger than 18 years, with rates 3 times as high among 0-to 14-year-olds (24 per 100 000 population). 20 Australian CSII uptake may have been influenced by the introduction of a government subsidy for low-income families with children with T1DM in 2008. 21 The sum of Au$6400 (or 80% of the device cost) may be available to persons with T1DM younger than 18 years that have an annual family income under Au$73 146 or receive government income support payments; varying support with the 20% copayment is available for those that qualify for the maximum device subsidy. Besides personal finance, CSII devices in Australia may also be obtained through private health insurance, clinical trial enrolment, or charitable donations. The majority (89%) of CSII users receive financial assistance to acquire their device, with almost all of these (97%) using private health insurance. 16 The consequence of this method of purchase is that use is more commonplace in higher socioeconomic areas (14% versus 6%). 16 Regardless of age, the consumables needed for patients with T1DM to use CSII technology are subsidized by the Australian Government, subject to eligibility criteria. 22 Despite increasing CSII use, there is little Australian information about the everyday experiences of young people with T1DM, or their intentions toward CSII use once they become adults. The aim of this study was to explore young people's attitudes, perceptions, and experiences with diabetes management, comparing those using with those not using CSII (ie, delivering insulin via injections), and to estimate the proportion likely to transition to adult services requiring initiation and/ or support for CSII use. 25 Responses were via visual analogue scales ranging from 0 to 100 mm with 5 anchor points; higher scores indicated greater knowledge, independence, and disturbance, scaling from "nothing" to "everything" (knowledge) and from "never" to "all the time" (other items).
| METHODS
Demographic data were sought, and residential area was categorized according to the Australian Standard Geographical Classification. 26 
| Attitudes and perceptions
Respondents' (n = 86) attitudes toward and perceptions of their diabetes management self-efficacy were largely positive. They mostly agreed that they handled themselves well with regard to their diabetes; were able to manage things related to their diabetes as well as most others; that they succeeded in the things they did to manage their diabetes; and were able to achieve management plans (Table 2) .
Mostly, they did not find it difficult to find effective solutions for management problems; efforts to change things about their diabetes worked; typical plans for diabetes management worked out well; and management turned out as planned. Reported attitudes and perceptions were not statistically significantly different between current CSII users and nonusers for individual items or the measure summaries ( Table 2) . Respondents were significantly more likely to report greater self-efficacy for diabetes self-management (have a higher PDSMS summary score) if they were younger, reported greater independence in their diabetes care, were less disturbed by their diabetes diagnosis, and reported lower most recent HbA 1c values (Table 3) . of 100). Again, there were no statistically significant differences in responses of current CSII users (n = 36) and nonusers (n = 51) for these .001
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They were more likely to report independence in their diabetes care overall if they were older, reported greater management self-efficacy (a higher PDSMS score), greater diabetes-related knowledge, and independence changing insulin dosages (Table 3) . The independent variables "Current CSII use, yes/no" and "Diabetes duration, overall" were removed from all models. reported a diabetes-related hospital admission (excluding an admission for T1DM diagnosis); overall, 33 respondents (30.8%) had used acute services for diabetes-related problems (excluding for T1DM diagnosis).
Again there was no statistically significant difference in responses of CSII users compared with nonusers (Table 4 ). Findings indicate the interrelated roles of perceived self-efficacy, diabetes-related knowledge, independence in diabetes management, and sense of disturbance caused by diabetes (Figure 1) . However, the influence of age appeared complex. Perhaps younger respondents perceived they had better diabetes self-efficacy and knowledge because they were shielded by their parents' contribution to their management; consistent with increasing independence in diabetes care overall with increasing age. With greater diabetes knowledge linked with greater sense of disturbance by their diabetes, education needs to be tailored to achieve better self-management, as it may otherwise function to cause anxiety or distress and may result in worse outcomes. The suggestion of greater disturbance in nonmetropolitan residents was perhaps linked to the greater isolation and lack of peer support experienced in rural areas 31 and warrants further exploration.
| Future preferences
Overall, the patterns of glycemic control reported by these participants could not be described as optimal. [32] [33] [34] 41, 42 Given the cost to provide CSII and the human resources required to support CSII users, discontinuance and any failure to improve real-life clinical outcomes are disappointing. 43 One reason for suboptimal outcomes might be that stretched diabetes teams, especially in rural areas, lack adequate specialist resources to provide the more complex and time-consuming support needed to optimize results. 35, 44 Where this is the case, service redesign is required to improve support particularly but not exclusively for CSII users. Other technologies such as video conferencing may also be of benefit 45 and should be explored.
Limitations of the study include the use of self-report data and sampling from only 1 regional health service. The sample size was relatively small, and the survey entailed only brief assessments of perceived disease knowledge, self-care independence, and sense of disturbance caused by diabetes. No data were available on participants' and their parents'/guardians' economic status, and we were, therefore, not able to consider whether financial concerns such as lack of access to private insurance or loss of the Australian Government subsidy for a CSII device at age 18 years may have, for example, influenced access or intention to use CSII. 21 The survey was completed, variously, by the young person, their parents, or both; findings, therefore, contain a mix of the young person's independent views and what the parents think their views are. We set out to obtain the views of young people and accepted that some parental input might be needed to obtain this, even to the extent of a parent responding as proxy. The strengths of the study are derived from successfully recruiting a "hard to access" group across a wide and diverse geographical and sociological area, the majority of whom completed the survey unaided. Incremental changes in technology since the study was undertaken are unlikely to yield different findings.
In summary, opportunities for enhanced diabetes service support were identified, with CSII in particular not currently appearing to achieve its full potential. Service structure needs to keep pace with the changes in technology and its rapid uptake by young people. Policy makers and managers should align service delivery to patient goals and preferences to maximize service as well as patient benefit. This must include regular access to multidisciplinary team support with specialist medical input, which is particularly lacking for CSII users and those outside metropolitan areas.
